Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vandetanib + Fulvestrant in Advanced Breast Cancer
NCT00752986Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Dec 2008
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vandetanib in breast cancer, sponsored by Sanofi. Started Dec 2008; status: terminated.
02
Drugs
vandetanib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00752986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00752986.